Precigen PGEN 深 沪
等待开盘 07-11 09:30:00 美东时间
5.285
-0.245
-4.43%
华盛通- 最 高5.50
- 今 开5.50
- 成交量 258.81万股
- 最 低 5.17
- 昨 收 5.53
- 总市值 188.42万
- 52周最高 6.04
- 市盈率 静 --
- 换手率 0.73%
- 52周最低 1.47
- 委 比 21.29%
- 总股本 0.00亿
- 历史最高 69.2096
- 量 比 0.57
- 振 幅 5.97%
- 历史最低 0.6513
- 每 手 1
- 风险率 0.91%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Precigen 看涨分析师观点与黯淡基本面相悖
核心标的为生物科技公司Precigen（股票代码：PGEN.O），当前整体走势中性，无明确自身基本面盈利支撑，分析师态度谨慎乐观。当前市场主线为监管政策持续收紧...
06-24 10:05
Precigen reports PAPZIMEOS trial data show 83% complete responses sustained at least 36 months in RRP
Precigen reports PAPZIMEOS trial data show 83% complete responses sustained at least 36 months in RRP Precigen highlighted long-term durability results for PAPZIMEOS in adult recurrent respiratory papillomatosis, already presented at the 2026 ASCO annual meeting. Follow-up showed many patients who f
06-15 18:40
美股大行评级 | 瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
05-29 18:09
Precigen Says FDA Grants Orphan Drug Exclusivity For PAPZIMEOS For Treatment Of Adults With Recurrent Respiratory Papillomatosis
FDA grants orphan drug exclusivity for PAPZIMEOS for the treatment of adults with recurrent respiratory papillomatosisSeven-year period of PAPZIMEOS market exclusivity is effective through August 14, 2032PAPZIMEOS, the
05-27 19:10
美股大行评级 | 阿里、京东、英伟达、思科等获多家大行上调目标价；Doximity、Dynatrace、Enovix、Wix.com等遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Autolus Therapeutics"买入"评级，目标价从9美元升至10美元；Maxim Group：维持Rezolute"买入"评级，目标价从4美元升至10美元
05-15 10:49
Papzimeos上市势头强劲 Precigen一季度业绩超预期股价大涨
一季度业绩：营收超预期，亏损大幅收窄 专注于精准医疗的商业阶段生物制药公司Precigen近日公布2026年第一季度财报，营收和每股收益双双超出市场预期...
05-15 03:05
HC Wainwright & Co. Maintains Buy on Precigen, Raises Price Target to $11
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Precigen (NASDAQ:PGEN) with a Buy and raises the price target from $10 to $11.
05-14 18:38
BUZZ-Precigen surges after Q1 revenue beat, narrower loss
BUZZ-Precigen surges after Q1 revenue beat, narrower loss ** Shares of drugmaker Precigen PGEN.O jumps 23.8% to $5.14 premarket ** PGEN late on Wednesday reported Q1 revenue of $23.25 million, beating analysts' average estimate of $20.8 million, according to data compiled by LSEG ** Net loss for the
05-14 18:29
Why Cisco Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
Cisco Inc (NASDAQ: CSCO) beat expectations and raised guidance with $15.84B revenue and $1.06 EPS. Shares jumped 17.3% in pre-market trading.
05-14 17:18
Transcript: Precigen Q1 2026 Earnings Conference Call
On Wednesday, Precigen (NASDAQ:PGEN) discussed first-quarter financial results ...
05-14 05:41
